InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the detailed record of transactions filed by Ando Goran. Director active across 1 company, notably EyePoint Pharmaceuticals, Inc.. Aggregated, 3 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €36k. History available since 9 February 2022. The latest transaction was disclosed on 21 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
ANDO GORAN is a Director at EyePoint Pharmaceuticals, Inc. (XNAS). He has 4 filings in total, and across the 4 recent filings sampled, purchases amount to EUR 35633, sales to EUR 0, between 2022-02-11 and 2024-08-21, with option exercise as the most frequent transaction nature.